Amid growing concerns over high drug prices in the United States, the federal government has proposed reforms to address the cost of prescription medications. With American consumers paying significantly more compared to other developed nations, policymakers are considering measures aimed at reducing costs, improving transparency, and examining the role of middlemen in the drug pricing system.